| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Roswell Park Cancer Institute and State University of New York at Buffalo, Buffalo, New York.
Correspondence: Address correspondence and reprint requests to: John F. Gibbs, MD, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263; Fax: 716-845-3434; E-mail: john.gibbs{at}roswellpark.org
| ABSTRACT |
|---|
|
|
|---|
Methods: Four hundred thirteen patients with esophageal cancer who presented to Roswell Park Cancer Institute from 1991 to 1998 were retrospectively reviewed. Clinical data, perioperative details, and postoperative courses were compared for patients older and younger than 70 years.
Results: One hundred forty-seven patients (36%) were older than 70 years. Risk factors, clinical symptoms, histology, and stage at presentation were equivalent for both age groups. A higher percentage of patients <70 years were candidates for curative resection. There were no significant differences between groups for estimated blood loss, intraoperative transfusions, length of stay, overall morbidity, or mortality. Only postoperative myocardial infarction and atrial fibrillation were increased in the older group. Excluding stage IV disease, there was a significant and similar improvement in median survival after resection for patients both <70 years and >70 years.
Conclusions: In conclusion, esophageal cancer in older patients warrants surgical resection because the benefit to the patient is the same as it is for younger patients, without a significant increase in operative morbidity or mortality.
Key Words: Esophageal cancer Esophagectomy Advanced age Aggressive surgical approach Postoperative complications Prognosis
| INTRODUCTION |
|---|
|
|
|---|
For several reasons, the decision to recommend an aggressive surgical approach to patients >70 years old with esophageal cancer is controversial. Many physicians are concerned about potentially higher morbidity and mortality rates in older patients after esophagectomy. Some physicians believe that older patients more often present with advanced-stage disease, possibly because of a longer time between the onset of symptoms and diagnosis in the geriatric population. Survival rates after esophagectomy are disappointing overall, and the life expectancy of elderly individuals is shorter than for their younger counterparts. For these reasons, many physicians and surgeons may favor palliative approaches rather than an aggressive surgical approach. To investigate the validity of these arguments, we retrospectively reviewed our experience with esophageal cancer in the elderly population.
| METHODS |
|---|
|
|
|---|
The statistical difference between groups was determined by using
2 tests or unpaired Students t-tests. A P value <.05 was considered significant.
| RESULTS |
|---|
|
|
|---|
|
|
Surgical Candidacy
As would be expected, a higher percentage of patients under the age of 70 years were deemed to be surgical candidates. Overall, 37% of patients under the age of 70 years underwent esophageal resection, compared with only 18% of patients >70 years (P < .01). The poor surgical candidates among patients >70 years more often had squamous cell carcinoma. For patients with adenocarcinoma, nearly half were candidates for resection in the <70 group, whereas 32% of patients in the >70 group were candidates. These numbers decreased to 19% and 12%, respectively, for patients with squamous cell carcinoma, despite the decreased number of patients >70 years with stage IV disease. Overall, 95 patients younger than 70 years with esophageal cancer had surgical resection, whereas 24 patients older than 70 years underwent resection.
Surgery
The characteristics of the patients undergoing curative resection for their esophageal cancer are listed in Table 3. Approximately 77% of the resections in patients <70 years were performed at Roswell Park Cancer Institute, and the remainder were performed at outside institutions with postoperative referral to Roswell Park either for adjuvant therapy or recurrent disease. Eighty-five percent of patients >70 years had their surgery performed at our institution. Seventy-six (80%) of 95 esophagectomies in patients <70 years were Ivor-Lewis resections with regional lymphadenectomies. There were nine thoracoabdominal approaches, five esophagogastrectomies, and three transhiatal resections. Twenty-two (85%) of 26 esophagectomies in the older age group were also Ivor-Lewis resections.
|
Adjuvant therapy was used equally in the two age groups. In patients <70 years, adjuvant therapy was administered in 59% of patients, whereas 41% were treated with surgery alone. These numbers were 54% and 46%, respectively, for patients >70 years. The type of adjuvant therapy was also equally distributed between the two groups, as indicated in Table 4.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
A reason physicians may be hesitant to aggressively treat esophageal cancer in older patients is the perception that the disease is more aggressive or advanced compared with in younger patients. Our data do not substantiate this belief. Older patients presented with a similar constellation of symptoms, with dysphagia and weight loss being the most common presentation. Likewise, there was no detectable delay in diagnosis in older patients. Patients older and younger than 70 years sought medical attention after a median of 2 months from the onset of symptoms. In accordance with this, the stage of disease at initial presentation was similar in both age groups. In fact, although not statistically significant, a greater percentage of older patients presented without evidence of metastatic disease at the time of presentation.
Despite the lower percentage of stage IV patients, a smaller portion of patients >70 years were considered to be suitable candidates for surgery. The most common reasons that patients were not deemed operative candidates were associated cardiac or pulmonary comorbidities. Thirty-seven percent of patients <70 years received esophagectomy, whereas only 18% of patients >70 years received surgery. Significant medical comorbidities were more prevalent in the patients with squamous cell carcinoma, in whom only 12% of patients >70 years were deemed surgical candidates (compared with 32% of older patients with adenocarcinoma). Given the association between squamous cell carcinoma and tobacco and alcohol use, it is not surprising that this population had a higher rate of comorbidities such as coronary artery disease or chronic obstructive lung disease. The lower rate of operability for older patients has been described previously.4 However, there are suggestions that the number of older patients being referred for operation is increasing.1,5
The safety of esophageal resection for older patients remains a controversial issue, because it has one of the highest operative mortality rates of any elective surgical procedure.6 Previously published reports describe extremely high mortality rates in older patients6,7 and implicate advanced age as a contraindication to esophagectomy.8 Our data, however, demonstrate no increase in mortality in older patients, confirming more recent reports from other institutions.5,9,10
Morbidity rates were also extremely similar. Esophageal resection in older patients did not result in greater blood loss, longer hospital stays, or an increased rate of surgical complications such as anastomotic leaks or postoperative strictures. With use of an Ivor-Lewis resection in the majority of cases for older and younger patients, we found no difference in the rate of pulmonary complications in the older age group, nor was there any difference in the rate of infectious complications. There were, however, a greater number of cardiac complications in the older group. Atrial fibrillation is a well-described complication of noncardiac thoracic surgery, and this occurred in 13% of patients <70 years and in 23% of patients >70 years, although this difference was not statistically significant. There were no cases of MI in the younger age group, whereas three patients >70 years had MIs. Given the decreased percentage of patients >70 years who made it to surgery, it is clear that there was a selection bias in this group of patients as opposed to the younger age group. At our institution, we routinely use multiple gated acquisition scan and pulmonary function tests to assess the cardiopulmonary status of potential surgical candidates. These data demonstrate that in appropriately selected patients >70 years old, esophageal resection can be performed as safely as in younger patients, without modification of surgical approach and without increased operative mortality.
Simply because an operation can be performed safely does not necessarily mean that it should be performed. It is believed that the overall poor prognosis of esophageal carcinoma combined with the high morbidity of esophagectomy and the short life expectancy of older patients precludes surgical resection. It is clear that the morbidity of esophageal resection in the older population does not carry a higher morbidity, but the question remains whether there is a survival benefit to make the procedure worthwhile. Overall median survival in this series was similar for both age groups (1.45 vs. 1.32 years). It is more important to note that the improvement in survival with surgical over nonsurgical management was the same for older patients as it was for younger patients. This was not secondary to adjuvant therapy, because it was applied equally between groups. Excluding stage IV disease, there was a significant improvement in the median survival of patients undergoing surgery for both patients <70 years (1.87 vs. .73 years; P < .01) and patients >70 years (1.82 vs. .85 years; P < .01). Although the mean survival was slightly lower (albeit not significant) in older patients undergoing surgery for stage IIb or III disease, a similar improvement in survival was seen over nonsurgical therapy. Therefore, the benefit to the patient >70 years was proportionally as great as for younger patients. The concept that a shorter life expectancy in older patients makes resection less beneficial does not seem true.
In conclusion, esophageal cancer in older patients warrants surgical resection because the benefit to the patient is the same as it is for younger patients, without a significant increase in operative morbidity or mortality. Because this population will have a higher percentage of cardiac and pulmonary risk factors, especially those with squamous cell carcinoma, thorough preoperative evaluation and a selective approach are reasonable. Likewise, an increased vigilance for cardiac complications should be applied postoperatively. However, age alone should not preclude esophageal resection for cancer in otherwise healthy patients.
| Footnotes |
|---|
Received for publication March 17, 2001. Accepted for publication October 25, 2001.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. P. Barbour, M. Jones, M. Gonen, D. C. Gotley, J. Thomas, D. B. Thomson, B. Burmeister, and B. M. Smithers Refining Esophageal Cancer Staging After Neoadjuvant Therapy: Importance of Treatment Response Ann. Surg. Oncol., October 1, 2008; 15(10): 2894 - 2902. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Internullo, J. Moons, P. Nafteux, W. Coosemans, G. Decker, P. De Leyn, D. Van Raemdonck, and T. Lerut Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years Eur. J. Cardiothorac. Surg., June 1, 2008; 33(6): 1096 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lagarde, F. J.W. ten Kate, J. B. Reitsma, O. R.C. Busch, and J. J. B. van Lanschot Prognostic Factors in Adenocarcinoma of the Esophagus or Gastroesophageal Junction J. Clin. Oncol., September 10, 2006; 24(26): 4347 - 4355. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Rice, A. M. Correa, A. A. Vaporciyan, N. Sodhi, W. R. Smythe, S. G. Swisher, G. L. Walsh, J. B. Putnam Jr, R. Komaki, J. A. Ajani, et al. Preoperative Chemoradiotherapy Prior to Esophagectomy in Elderly Patients is Not Associated With Increased Morbidity Ann. Thorac. Surg., February 1, 2005; 79(2): 391 - 397. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |